Reported 1 day ago
LifeStance Health Group, Inc. (NASDAQ:LFST) has marked a successful fourth consecutive day of gains, rising 10.94% to $5.17 following robust second-quarter earnings. The company reported an 84% reduction in net loss to $3.8 million and an 11% increase in revenue to $345.3 million, largely driven by a growth in clinician visits. CEO Dave Bourdon expressed pride in the team's performance, maintaining a full-year revenue growth target of $1.4 billion to $1.44 billion.
Source: YAHOO